Anargyros Kapetanakis

Anargyros Kapetanakis

Auto-generated profile, based on publicly available information

Anargyros Kapetanakis

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thermi, Greece

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2023 in American Journal of Hematology
Verified
Journal Article
Open access
Andrea VisentinAndrea Visentin
Andrea Visentin
TCThomas Chatzikonstantinou
Thomas Chatzikonstantinou
LSLydia Scarfò
Lydia Scarfò
AKAnargyros Kapetanakis
Anargyros Kapetanakis
CDChristos Demosthenous
Christos Demosthenous
PGPaolo Prospero Ghia
Paolo Prospero Ghia
In this retrospective international multicenter study, we describe the clinical characteristics and outcomes of patients with chronic lymphocytic leukemia (CLL) and related disorders (small lymphocytic lymphoma and high‐count monoclonal B lymphocytosis) infected by SARS‐CoV‐2, including the development of post‐COVID condition. Data from 1540 patients with CLL infected by SARS‐CoV‐2 from January 2020 to May 2022 were included in the analysis and assigned to four phases based on cases disposition and SARS‐CoV‐2 variants emergence. Post‐COVID condition was defined according to the WHO criteria. Patients infected during the most recent phases of the pandemic, though carrying a higher comorbidity burden, were less often hospitalized, rarely needed intensive care unit admission, or died compared to patients infected during the initial phases. The 4‐month overall survival (OS) improved through the phases, from 68% to 83%, p = .0015. Age, comorbidity, CLL‐directed treatment, but not vaccination status, emerged as risk factors for mortality. Among survivors, 6.65% patients had a reinfection, usually milder than the initial one, and 16.5% developed post‐COVID condition. The latter was characterized by fatigue, dyspnea, lasting cough, and impaired concentration. Infection severity was the only risk factor for developing post‐COVID. The median time to resolution of the post‐COVID condition was 4.7 months. OS in patients with CLL improved during the different phases of the pandemic, likely due to the improvement of prophylactic and therapeutic measures against SARS‐CoV‐2 as well as the emergence of milder variants. However, mortality remained relevant and a significant number of patients developed post‐COVID conditions, warranting further investigations.

15 July 2022 in HIV Medicine
Verified
Journal Article
Open access
DTDimitra Tsakona
Dimitra Tsakona
AKAnargyros Kapetanakis
Anargyros Kapetanakis
DKDimitrios Kyrou
Dimitrios Kyrou
NVNikolaos Vrontaras
Nikolaos Vrontaras
AXAliki Xochelli
Aliki Xochelli
CKChristina Karamanidou
Christina Karamanidou
Objectives: Frailty is known to affect people living with HIV prematurely, compared to the ageing seronegative population. In this cross‐sectional study, we aimed to assess frailty prevalence in people living with HIV in Greece and find associations of frailty criteria with clinical data.Methods: Demographic and clinical data were collected from 477 participants in six HIV clinics. Fried's frailty phenotype was used to assess frailty prevalence, and participants were classified as frail, pre‐frail or robust. Associations of several factors with overall frailty phenotype, as well as with frailty criteria, were explored.Results: The median age was 43 years old (IQR = 51.5) and 444/477 (93%) were men. Most of the participants (429/477, 93.5%) had an undetectable HIV viral load, and a CD4 cell count over 500 cells/μl (366/477, 76.7%). Frailty assessment classified 285/477 (62.1%) as robust, 155/477 (33.8%) as pre‐frail and 19/477 (4.1%) as frail. Weakness in grip strength was the most prevalent criterion (128/477, 26.8%), followed by exhaustion (46/477, 9.6%). Lower CD4 cell count, history of AIDS diagnosis, CNS disorders, psychiatric diagnoses, and polypharmacy were strongly associated with frailty.Conclusions: Although the prevalence of frailty in people living with HIV in Greece is uncommon, when combined with pre‐frailty over a third of people are affected, which requires attention in clinical practice. The physical and psychological aspects of frailty highlight the need for a holistic approach to prevent or counteract it. The diverse associations of frailty criteria with HIV‐related and non‐HIV‐related factors suggest a possible variation in people's different healthcare needs.

20 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAnargyros Kapetanakis
Anargyros Kapetanakis
GKGEORGIOS KARAKATSOULIS
GEORGIOS KARAKATSOULIS
DKDimitrios Kyrou
Dimitrios Kyrou
INIliana Ntourou
Iliana Ntourou
NVNikolaos Vrontaras
Nikolaos Vrontaras
CKChristina Karamanidou
Christina Karamanidou
Objective: Despite the significant advances in healthcare, people living with HIV still face challenges that affect their quality of life (QoL), both in terms of their physical state as represented by frailty and of their illness perceptions (IP). The aim of this study was to unravel the associations between these constructs (QoL, frailty, IP). Methods: This multicenter, cross-sectional study included 477 people living with HIV (93% male; median age = 43 years, IQR = 51.7) from six HIV clinics in Greece. Frailty phenotype, QoL and IP were assessed using Fried’s criteria, EuroQoL (EQ-5D-5L) and Brief Illness Perception Questionnaire (BIPQ), respectively. Network analysis model was utilized. Results: Among frailty criteria, exhaustion had the highest expected influence, while the strongest correlation concerns exhaustion and weak grip strength (pr = 0.14). Regarding the QoL items, usual activities displayed the highest expected influence. The correlations of pain/discomfort with mobility (pr = 0.31), and usual activities with self-care (pr = 0.34) were the strongest. For the BIPQ items, the strongest correlation was found between illness concern and emotional response (pr = 0.45), whereas the latter item was the one that displayed the highest expected influence. Three communities were formed: 1) personal control, treatment control and coherence, 2) the frailty items with mobility, self-care, usual activities, and pain/discomfort, and 3) the rest BIPQ items with anxiety/depression. Identity displayed the highest bridge strength, followed by pain/discomfort, usual activities and consequences. Conclusions: The interplay between QoL, frailty, and IP in people living with HIV requires clinical attention. Self-reported exhaustion, slow walking speed, and low physical activity affect the physical QoL dimensions, while anxiety/depression is strongly associated with illness-related concern and perceived emotional effects, leading to psychological distress. Symptom management can improve QoL, and information on the disease and treatment can enhance control over the disease. Developing interventions to address QoL, frailty, and IP is crucial.

20 March 2025 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
NVNikolaos Vrontaras
Nikolaos Vrontaras
GKGeorge Koulierakis
George Koulierakis
DKDimitrios Kyrou
Dimitrios Kyrou
AKAnargyros Kapetanakis
Anargyros Kapetanakis
AXAliki Xochelli
Aliki Xochelli
CKChristina Karamanidou
Christina Karamanidou
Purpose: The present study aims to investigate the experiences of hematologists providing care to patients with hematological malignancies, whose care is pertinent to oncology. Methods: Semi-structured interviews with 30 hematologists across Greece were conducted. The interviews took place over the course of 6 months at 2020. Reflexive thematic analysis was employed for data analysis. Results: Three key themes (personal impact, organizational framework, and relating to patients) and eight subthemes were generated: (1) Hematologists were greatly affected on a personal level, as they had poor life-work balance and impacted social relationships. They experienced a great emotional toll, sometimes questioning the meaning of their work. They frequently struggled with loss, by witnessing people’s passing. Nevertheless, they reported coping better over time. (2) On an organizational level, hematologists supported each other emotionally, but only rarely had formal support in managerial or administrative recourses. They were also hindered by structural restraints, both in terms of limited psychosocial training and supportive services. (3) Hematologists’ relationship with their patients increased their job satisfaction. However, they strived to keep boundaries while balancing how close they got to their patients. Conclusion: High job demands, organizational shortcomings, and emotional challenges negatively impact their well-being and pose the risk of developing compassion fatigue or burnout. At the same time, individual resources, teamwork, and strong personal relationships emerged as crucial coping elements, providing meaning and resilience. Psychosocial training and institutional support should be offered both personally and professionally to enhance hematologists’ well-being and reduce potential turnover.